Molecular pathology in basal cell cancer with p53 as a genetic marker

Oncogene

Volumn 15, Issue 9, 1997, Pages 1059-1067

  Pontén, Fredrik ^a   Berg, Cecilia ^b   Ahmadian, Afshin ^b   Ren, Zhi Ping ^a   Nistér, Monica ^a   Lundeberg, Joakim ^b   Uhlén, Mathias ^b   Pontén, Jan ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

BCC; Clonality; Heterogeneity; LOH; Mutation; p53

Indexed keywords

MICROSATELLITE DNA; PROTEIN P53;

ADULT; AGED; ALLELE; ARTICLE; BASAL CELL; BASAL CELL CARCINOMA; CELL CLONE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EPIDERMIS; EXON; FEMALE; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC MARKER; GERM LINE; HAPLOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MISSENSE MUTATION; MOLECULAR CLONING; PRIORITY JOURNAL;

EID: 0030881082     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201435     Document Type: Article

References (36)

1. Berg C, Hedrum A, Holmberg A, Pontén F, Uhlén M and Lundeberg J. (1995). Clin. Chem., 41, 1461-1466.
2. Brash D, Ziegler A, Jonason A, Simon J, Subrahmanyam K and Leffell D. (1996). J. Invest. Dermat. Symp. Proc., 1, 136-142.
3. Brash DE, Rudolph JA, Simon JA, Lin A, Mckenna GJ, Baden HP, Halperin AJ and Pontén J. (1991). Proc. Natl. Acad. Sci., 88, 10124-10128.
4. Campbell C, Quinn AG, Ro Y-S, Angus B and Rees JL. (1993). J. Invest. Dermatol., 100, 746-748.
5. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH and Reid BJ. (1996). Science, 267, 1353-1356.
6. Diffey BL, Tate TJ and Davis A. (1979). Phys. Med. Biol., 24, 931-939.
7. Friend S. (1994). Science, 265, 334-335.
8. Futreal PA, Söderkvist P, Marks JR, Iglehart JD, Cochran C, Barrett JC and Wiseman RW. (1992). Cancer Res., 52, 2624-2627.
9. Gallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, McLean DI and Threlfall WJ. (1995). Arch. Dermatol., 131, 157-163.
10. Hahn H, Wiking C, Zaphiropoulos PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrarrd B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B and Bale AE. (1996). Cell, 85, 841-851.
11. Harris CC. (1995). Ann. Symp. Biol. Skin, 1, 115-118.
12. Hedrum A, Pontén F, Ren Z, Lundeberg J, Pontén J and Uhlén M. (1994). BioTechniques, 17, 118-129.
13. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R and Harris CC. (1996). Nucleic Acids Res., 24, 141-146.
14. Hultman T, Ståhl S, Homes E and Uhlén M. (1989). Nucleic Acids Res., 17, 4937-4946.
15. Imayama S, Yashima Y, Higuchi R and Urabe H. (1987). Am. J. Pathol., 128, 497-504.
16. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein Jr EH and Scott MP. (1996). Science, 272, 1668-1671.
17. Jones MH and Nakamura Y. (1992). Genes Chrom. Cancer, 5, 89-90.
18. Kanjilal S, Strom SS, Clayman GL, Weber RS, El-Naggar AK, Kapur V, Cummings KK, Hill LA, Spitz MR, Kripke ML and Ananthaswamy HN, (1995). Cancer Res., 55, 3604-3609.
19. Knudson Jr AG. (1993). Proc. Natl. Acad. Sci., 90, 10914-10921.
20. Kress S, Sutter C, Strickland PT, Mukhtar H, Schweizer J and Schwartz M. (1992). Cancer Res., 52, 6400-6403.
21. Kricker A, Armstrong BK and English DR. (1994). Cancer Causes Control, 5, 367-392.
22. Kubo Y, Urano Y, Yoshimoto K, Iwahana H, Fukuhara K, Arase S and Itakura M. (1994). J. Invest. Dermatol., 102, 440-444.
23. Lane DP. (1992). Nature, 358, 15-16.
24. Levine AJ, Momand J and Finlay CA. (1991). Nature, 351, 453-456.
25. Madsen A. (1965). Acta Pathol. Microbiol. Scandinav., Suppl. 177, 9-63.
26. Malkin D. (1994). Biochim. Biophys. Acta, 1198, 197-213.
27. Pontén F, Berne B, Ren Z, Nistér M and Pontén J. (1995). J. Invest. Dermatol., 105, 402-406.
28. Pontén F, Ren Z, Nistér M, Westermark B and Pontén J. (1994). J. Invest. Dermatol., 102, 304-309.
29. Rady P, Scinicariello F, Wagner Jr RF and Tyring SK. (1992). Cancer Res., 52, 3804-3806.
30. Ren Z-P. (1996). Role of mutations in the p52 gene for the development of human squamous cell skin cancer. Comprehensive Summaries of Uppsala dissertations from the faculty of medicine. No. 605, Acta universitatis upsaliensis.
31. Ren Z-P, Hedrum A, Pontén F, Nistér M, Ahmadian A, Lundeberg J, Uhlén M and Pontén J. (1996a). Oncogene, 12, 765-773.
32. Ren Z-P, Pontén F, Nistér M and Pontén J. (1996b). Int. J. Cancer (Pred. Oncol.), 66, 174-182.
33. Rüther U. (1982). Nucleic Acids Res., 10, 5765-5772.
34. van Scott EJV and Reinertson RP. (1961). J. Invest. Dermatol., 36, 109-117.
35. von Domarus H and Stevens PJ. (1984). J. Am. Acad. Dermatol., 10, 1043-1060.
36. Ziegler A-M, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE and Brash DE. (1993). Proc. Natl. Acad. Sci. USA. 90, 4216-4220.